NRCNRC Health

$21.91+87% 1Y

$21.91

$11.2252 weeks$22.85

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though cheap against its own history.

1 good, 2 without data

What the price assumes~+7% a yearderived · Jun 30, 2026

Priced for ~7% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangecheaper than 87% of its own historyderived

Cheap vs its own history: P/E 17.9 vs a 26.6 median over 24 quarters (−33% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Today's price asks for 7.1% free cash flow growth a year; over the last three years NRC Health delivered +0.60%, so the price is ahead of the record.

3.41

Price / sales · no trailing P/E on file: measured against sales instead

Free cash flow yield: 4.5%
Free cash flow yield · Health Information Services median 4.5%
Growth the price implies: +7.1%
Growth the price implies · The price pays for +7.1% free cash flow growth a year for a decade; the business has delivered +0.60% a year over the last three.
Price / book: 72.8
Price / book · as of 2026-Q2

Details›

What the market has paid for these earnings: 24 quarters of its own multiple × $49.74 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$1,166.76
Its own P/E history, median	$1,323.31
Its own P/E history, upper quartile	$1,502.07
52-week range	$11.22 – $22.85
Today	$21.91

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.